切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2015, Vol. 04 ›› Issue (01) : 20 -25. doi: 10.3877/cma.j.issn.2095-3224.2015.01.05

所属专题: 文献

专家论坛

保肛手术的理想愿望与现实
王锡山1()   
  1. 1. 150086 哈尔滨医科大学附属第二医院结直肠肿瘤外科 哈尔滨医科大学大肠癌研究所
  • 收稿日期:2014-12-30 出版日期:2015-02-25
  • 通信作者: 王锡山
  • 基金资助:
    国家自然科学基金(81272706)

The ambition and reality of sphincter preserving surgery

Xi-shan WANG1,()   

  1. 1. Department of Colorectal Cancer Surgery, The Second Affiliated Hospital, The Colorectal Cancer Institute, Harbin Medical University, Harbin 150086, China
  • Received:2014-12-30 Published:2015-02-25
  • Corresponding author: Xi-shan WANG
  • About author:
    Corresponding author: WANG Xi-shan, Emai:
引用本文:

王锡山. 保肛手术的理想愿望与现实[J]. 中华结直肠疾病电子杂志, 2015, 04(01): 20-25.

Xi-shan WANG. The ambition and reality of sphincter preserving surgery[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2015, 04(01): 20-25.

保肛手术已成为中低位直肠癌的首选术式,随着现代医学模式的转变和治疗手段的进步,要求外科医生不仅需要"保肛",还需要"保功能",但腹会阴联合切除术在部分患者中仍是客观必需的。在治疗过程中,需要医生综合考虑患者自身因素,结合手术技巧,个体化选择术式。只有不断完善治疗过程中各个环节的质量控制,建立规范化的手术标准,才能使得更多的患者能够获益。

Sphincter preserving surgery has become the preferred technique in low rectal cancer treatanent.With the transformation of modern medical model and treatment methods progress, it requires that the surgeon needs not only "sphincter preserving" , but also "function preserving" . However abdominoperineal resection in some patients is still required.In the course of treatment, doctors need to consider various aspects of patients, combined with surgery skills, give individual choice of operation.In order to benefit more patients, doctors should improve the quality control of each step in the treatment process and establish standardized operation methods.

[1]
Bordeianou L, Maguire LH, Alavi K,et al.Sphincter-sparing surgery in patients with low-lying rectal cancer:techniques,oncologic outcomes,and functional results.J Gastrointest Surg,2014,18(7):1358-1372.
[2]
Heald RJ, Ryall RD.Recurrence and survival after total mesorectal excision for rectal cancer.Lancet,1986,1:1479-1482.
[3]
Park SY, Choi GS, Park JS,et al.Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer:A randomized,double-blind,placebo-controlled trial.Surgery,2015,157:64-71.
[4]
Radovanovic Z, Petrovic T, Radovanovic D,et al.Single versus double stapling anastomotic technique in rectal cancer surgery.Surg Today,2014,44:1026-1031.
[5]
Jeong SY, Park JW, Nam BH,et al.Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy(COREAN trial):survival outcomes of an open-label,non-inferiority,randomised controlled trial.Lancet Oncol,2014,15:767-774.
[6]
Ng SS, Lee JF, Yiu RY,et al.Laparoscopic-assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer:a prospective,randomized trial.Surg Endosc,2014,28:297-306.
[7]
王锡山.低位直肠癌保肛手术研究进展.中国普外基础与临床杂志,2012,19:590-593.
[8]
王锡山.直肠癌保肛系列问题探讨.实用肿瘤学杂志,2006,20:480-483.
[9]
王锡山.低位超低位吻合保肛手术标准建立的意义与思考.中华胃肠外科杂志,2013,16:613-615.
[10]
王锡山,姜世雄,石清涛,等.中低位直肠癌逆向转移的研究.中华胃肠外科杂志,2008,11:128-131.
[11]
陈瑛罡,王锡山,王贵玉,等.直肠癌肛侧肠管分子边界的研究.中华实验外科杂志,2008,25:804.
[12]
Maas M, Nelemans PJ, Valentini V,et al.Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer:a pooled analysis of individual patient data.Lancet Oncol,2010,11:835-844.
[13]
Maas M, Beets-Tan RG, Lambregts DM,et al.Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.J Clin Oncol,2011,29:4633-4640.
[14]
van der Pas MH, Haglind E, Cuesta MA,et al.Laparoscopic versus open surgery for rectal cancer(COLOR II):short-term outcomes of a randomised,phase 3 trial.Lancet Oncol,2013,14:210-218.
[15]
Liu Z1, Wang GY, Chen YG,et al.Cost comparison between hand-assisted laparoscopic colectomy and open colectomy.J Laparoendosc Adv Surg Tech A,2012,22:209-213.
[16]
王锡山,王贵玉,刘正,等.经阴道入路直肠肿瘤切除术二例.中华胃肠外科杂志,2011,14:325-326.
[17]
王锡山.关于结直肠功能外科与类NOTES技术的思考.中华结直肠疾病电子杂志,2014,3(4):2-4.
[18]
汤庆超,陈瑛罡,王锡山.腹部无切口经阴道拉出切除标本的腹腔镜中位直肠癌根治术.中华胃肠外科杂志,2013,14:121-123.
[19]
王猛,刘正,陈瑛罡,等.腹部无切口经阴道拖出标本的腹腔镜下高位直肠癌根治术.中华结直肠疾病电子杂志,2014,5:71-72.
[20]
刘正,王贵玉,王锡山.腹部无切口经肛门拖出标本的腹腔镜下直肠癌根治术.中华胃肠外科杂志,2013,16:1215-1217.
[21]
刘正,王贵玉,王锡山.腹部无切口经肛门外切除肿瘤的腹腔镜直肠癌根治术.中华消化外科杂志,2014,13:102-104.
[22]
姜争,陈瑛罡,王锡山.腹部无切口经直肠肛门外翻切除标本的腹腔镜低位直肠癌根治术.中华胃肠外科杂志,2014,5:499-501.
[23]
Juul T, Ahlberg M, Biondo S,et al.Low anterior resection syndrome and quality of life:an international multicenter study.Dis Colon Rectum,2014,57:585-591.
[24]
王锡山.结直肠肿瘤治疗的微创和功能外科理念在实践与探索中前行.中华结直肠疾病电子杂志,2013,2(2):106-108.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[7] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[8] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[9] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[10] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[11] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[12] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[13] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[14] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[15] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
阅读次数
全文


摘要